ArticleTranslational andrology and urology2025
Effect of a novel implantable tibial nerve stimulation system on overactive bladder in pigs.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Overactive bladder (OAB) is a common and burdensome condition characterized by urgency, frequency, and urinary incontinence. While tibial nerve stimulation (TNS) has emerged as a minimally invasive neuromodulation therapy for OAB, current systems are limited by external devices, frequent hospital visits, and inconsistent stimulation. This study aims to investigate the safety and efficacy of a novel implantable TNS system for treating OAB in pigs. Methods: Three male Bama miniature pigs (25-28 kg) received bilateral implantation of a novel battery-free, wireless implantable TNS system. The right-side device was activated as the treatment side, and the left-side device remained inactive as a control. Postoperative observations continued for 30 days, including assessments of general health, body weight, and X-ray monitoring of device position. OAB was induced by intravesical infusion of 5% acetic acid. Bladder pressure-volume curves were measured under baseline, OAB-induced (control), and TNS-stimulated (experimental) conditions. Histological examination of tissues surrounding the implants was conducted using hematoxylin and eosin staining to assess inflammation. Results: All pigs remained in good health throughout the study, with stable weight gain and no adverse events. The implanted devices showed no migration and maintained stable function. Compared with baseline, bladder capacity was significantly reduced in the control group after OAB induction (P<0.05), and significantly increased in the experimental group after stimulation (average improvement of 24.4%, P<0.05). Histological analysis revealed no significant inflammatory reactions at electrode contact sites or in surrounding tissues between the experimental and control groups (P>0.05). Conclusions: The novel implantable TNS system demonstrated excellent safety, biocompatibility, and efficacy in reducing OAB symptoms in pigs. These findings support its potential as a convenient and effective long-term neuromodulation therapy for OAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.